Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Cinnarizine

Cinnarizine

pharmaceutical raw materials
Cinnarizine structure

Cinnarizine 

structure
  • CAS No:

    298-57-7

  • Formula:

    C26H28N2

  • Chemical Name:

    Cinnarizine

  • Synonyms:

    Piperazine,1-(diphenylmethyl)-4-(3-phenyl-2-propen-1-yl)-;Piperazine,1-cinnamyl-4-(diphenylmethyl)-;Piperazine,1-(diphenylmethyl)-4-(3-phenyl-2-propenyl)-;1-(Diphenylmethyl)-4-(3-phenyl-2-propen-1-yl)piperazine;R 516;R 1575;N-Benzhydryl-N′-cinnamylpiperazine;1-Cinnamyl-4-(diphenylmethyl)piperazine;Cinnarizine;Dimitronal;1-Diphenylmethyl-4-cinnamoylpiperazine;Marisan;Midronal;Mitronal;Stugeron;Glanil;Labyrin;Dimitron;Stutgeron;Stutgin;Toliman;Folcodal;Sepan;1-Benzhydryl-4-cinnamylpiperazine;Lazeta;1-Cinnamyl-4-benzhydrylpiperazine;1-(3-Phenylallyl)-4-(diphenylmethyl)piperazine;Artate;Cinazyn;Apotomin;Corathiem;Cinaperazine;Katoseran;Giganten;Cerepar;Spaderizine;Cinnageron;Cerebolan;Hilactan;Cinnipirine;Denapol;Eglen;Carecin;Cinnacet;Sedatromin;Ixterol;Siptazin;Aplactan;Olamin;516MD;Processine;Aplexal;Cinarizine;Vergo;Stunarone

  • Categories:

    Active Pharmaceutical Ingredients  >  Circulatory System Drugs

Description

Cinnarizine is an antihistamine and a calcium channel blocker, promote cerebral blood flow, used to treat cerebral apoplexy, post-trauma cerebral symptoms, and cerebral arteriosclerosis.

Cinnarizine Basic Attributes

368.51

368.51

206-064-8

2933599090

Characteristics

6.5

5.8

white powder

1.13 g/cm3

120.2 °C

505.8°C at 760 mmHg

229.8±14.6 °C

1.626

soluble in chloroform at 50mg/ml

Refrigerator

2.35E-10mmHg at 25°C

LD50 oral in rat: > 6500mg/kg

Safety Information

3077

2

20/22-36/37/38-42/43

22-24/25-36-26

TL3430000

Xn

P273, P501

H413

Cinnarizine Use and Manufacturing

Methods of Manufacturing

General procedure: General procedure for amination of allylic alcoholsAllylic alcohols 1 (0.4 mmol), Pd(Xantphos)Cl2 (0.02 mmol, 5 molpercent), amines 2(0.6 mmol) and 2-PrOH (1.5 mL) were added to a 25 mL flame-dried Young-typetube under nitrogen atmosphere. The mixture was stirred at room temperature for 12hrs. After concentrated under reduced pressure, the residue was purified by flashcolumn chromatography on silica gel and eluted with EtOAc/PE (1/100-1/1) to affordthe desired product 3.General procedure: Benzyltriphenyl phosphonium chloride (17.9 mmol) (prepared according to thereported procedure [31]) was added to a solution of 4a–c (17.0 mmol) in dichloromethane (50 ml) under N2 atmosphere. The mixture was cooled to 5 °C and t-BuOK (41.3 mmol) was added under stirring. After completion, the reaction mixture was quenched into water (100 ml). The organic layer was separated, dried over anhydrous sodium sulfate, and concentrated under vacuum to obtain crude material 5a–c. The crude was then subjected to column purification over SiO2 using EtOAc/hexane as an eluent to afford 1a–c[25] and 6a–c in pure form.

Uses

For the treatment of vertigo/meniere's disease, nausea and vomiting, motion sickness and also useful for vestibular symptoms of other origins.

Drug Function and Efficacy

Extract from the above information

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

  • FDC LTD

    United States United States
    Active
  • Jinyao Pharmaceutical Co., Ltd.

    China China
    Active
  • Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd.

    China China
    Active

Recommended Suppliers of Cinnarizine

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.